Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy - Faculté des Sciences de Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal of Neuromuscular Diseases Année : 2021

Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy

Résumé

Amyotrophic lateral sclerosis (ALS) is a devastating and incurable motor neuron (MN) disorder affecting both upper and lower MNs. Despite impressive advances in the understanding of the disease's pathological mechanism, classical pharmacological clinical trials failed to provide an efficient cure for ALS over the past twenty years. Two different gene therapy approaches were recently approved for the monogenic disease Spinal muscular atrophy, characterized by degeneration of lower MNs. This milestone suggests that gene therapy-based therapeutic solutions could be effective for the treatment of ALS. This review summarizes the possible reasons for the failure of traditional clinical trials for ALS. It provides then a focus on the advent of gene therapy approaches for hereditary forms of ALS. Specifically, it describes clinical use of antisense oligonucleotides in three familial forms of ALS, caused by mutations in SOD1, C9orf72 and FUS genes, respectively. Clinical and pre-clinical studies based on AAV-mediated gene therapy approaches for both familial and sporadic ALS cases are presented as well. Overall, this overview highlights the potential of gene therapy as a transforming technology that will have a huge impact on treatment perspective for ALS patients and on the design of future clinical trials.
Fichier principal
Vignette du fichier
jnd_2021_8-1_jnd-8-1-jnd200531_jnd-8-jnd200531.pdf (939.47 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03346426 , version 1 (16-09-2021)

Identifiants

Citer

Marisa Cappella, Pierre-François Pradat, Giorgia Querin, Maria Grazia Biferi. Beyond the Traditional Clinical Trials for Amyotrophic Lateral Sclerosis and The Future Impact of Gene Therapy. Journal of Neuromuscular Diseases, 2021, 8 (1), pp.25 - 38. ⟨10.3233/jnd-200531⟩. ⟨hal-03346426⟩
86 Consultations
317 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More